Back
Royalty Pharma PLC Vs. Amicus Therapeutics Industry Stock Comparison
Sell
27
RPRX
Royalty Pharma PLC
Last Price:
26.41
Seasonality Move:
3.06%
Sell
29
FOLD
Amicus Therapeutics
Last Price:
9.68
Seasonality Move:
7.75%
Sell
27
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $26.43. The Score for RPRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $9.66. The Score for FOLD is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $26.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $9.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
RPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 45.67 | Sell |
| Chaikin Money Flow: | -820430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.05 - 27.31) | Sell |
| Bollinger Bands (100): | (26.56 - 28.44) | Sell |
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 32.67 | Sell |
| Chaikin Money Flow: | 481094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.02 - 11.72) | Sell |
| Bollinger Bands (100): | (10.17 - 11.55) | Sell |
RPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26 | Buy |
| 20-day SMA: | 26.51 | Sell |
| 50-day SMA: | 27.29 | Sell |
| 200-day SMA: | 28.02 | Sell |
| 8-day EMA: | 26.21 | Buy |
| 20-day EMA: | 26.48 | Sell |
| 50-day EMA: | 27.03 | Sell |
| 200-day EMA: | 27.96 | Sell |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.76 | Sell |
| 20-day SMA: | 10.65 | Sell |
| 50-day SMA: | 10.81 | Sell |
| 200-day SMA: | 10.98 | Sell |
| 8-day EMA: | 9.84 | Sell |
| 20-day EMA: | 10.35 | Sell |
| 50-day EMA: | 10.71 | Sell |
| 200-day EMA: | 11.01 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.31 per share.
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
Royalty Pharma PLC Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amicus Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||